3 New Strong Buy Ratings from Top-Rated Analysts: 03/03/2026

Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

• Nvidia (NVDA) — AI‑chip powerhouse with massive upside potential.
• Jazz Pharmaceuticals (JAZZ) — Specialty pharma poised for strong growth and pipeline catalysts.
• V2x (VVX) — Defense tech innovator with compelling earnings momentum.

P.S. Get more alerts like this daily … Try WallStreetZen Premium.



A note from our sponsors...

1. Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)

Jazz Pharmaceuticals specializes in sleep disorder and oncology therapies, with a leading focus on narcolepsy. After beating Q4 earnings and surpassing $1 billion in CBD drug sales, the company is poised for continued growth in specialty pharmaceuticals.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $188.99 — get current quote

Max 1-year forecast: $275.00

Why we're watching:

• Analyst support: Strong conviction from Wall Street with 7 Strong Buy ratings, 3 Buy ratings, and only 1 Hold from 11 analysts covering the stock. See the ratings
• Barclays analyst Etzer Darout (a top 2% rated analyst) recently initiated coverage with a Strong Buy rating and $224 price target, citing the company's compelling growth opportunity with its current pipeline and market dynamics.
• Needham analyst Ami Fadia (a top 1% rated analyst) maintains a Buy rating with a $235 price target, noting the company's expanding market presence and favorable growth outlook.
• Industry ranking context: JAZZ is currently the 3rd highest-rated stock out of 475 in the Biotech industry, which has an Industry Rating of F, making Jazz's Strong Buy rating particularly noteworthy in a challenging sector.
• Zen Rating highlights: As an A (Strong Buy) rated stock, JAZZ is in the top 5% of tickers we track based on a careful review of 115 factors proven to drive stock growth, cementing its top spot among biotech stocks with strong forecasted EPS growth for the next 3 years.
• Component Grades: Jazz scores an A in both Value and Growth, complemented by a B in Financials, reflecting strong operational fundamentals and expansion potential. See all 7 Zen Component Grades here

2. V2x Inc (NYSE: VVX)

V2x Inc delivers advanced aerospace and defense solutions, supporting military operations and emerging technologies. After beating Q4 earnings and securing the ATSP5 contract, the company is driving innovation for the next generation of warfighters.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $70.57 — get current quote

Max 1-year forecast: $90.00

Why we're watching:

• Analyst support: VVX enjoys 2 Strong Buy ratings from the analysts we track, with a max price target that suggests nearly 30% potential upside. See the ratings
• That high rating comes from BTIG analyst Andre Madrid (a top 8% rated analyst); the stock also has a Strong Buy rating from Jonathan Siegmann of Stifel Nicolaus, a top 19% analyst. 
• Industry ranking context: VVX is currently the #1 highest-rated stock in the Defense industry, which has an Industry Rating of C, demonstrating strong relative performance in the sector.
• Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr if V2x achieves its impressive earnings growth forecasts of +44% annually, this seems like a reasonable benchmark. 
• Component Grades: The company excels with an A in Value and B grades for Growth, Sentiment, and Safety, reflecting strong fundamentals and positive market positioning despite operating in a competitive defense landscape. See all 7 Zen Component Grades here

3. Nvidia (NASDAQ: NVDA)

The OG! NVIDIA Corporation leads the world in GPUs and AI computing, powering gaming, data centers, and autonomous vehicles. Its cutting-edge chips are at the heart of the AI revolution, driving the next generation of intelligent applications.

Zen Rating: B (Buy) — see full analysis

Recent Price: $177.19 — get current quote

Max 1-year forecast: $352.00

Why we're watching:

• Analyst support: Wall Street remains bullish on NVDA with 23 Strong Buy ratings, 8 Buy ratings, and only 1 Hold out of 32 analysts covering the stock. See the ratings
• Citigroup analyst Atif Malik (a top 1% rated analyst) recently maintained his Strong Buy rating with a $300 price target, representing +69% upside potential.
• Morgan Stanley's Joseph Moore (a top 1% rated analyst) maintains his Strong Buy rating with a $260 price target following the company's continued strength in AI infrastructure demand.
• Industry ranking context: NVDA is currently the 4th highest-rated stock in the Semiconductor industry, which has an Industry Rating of B. (What ranks higher than NVDA? See the full list here.)
• Zen Rating highlights: Buy (B) stocks average +19.88%/yr — NVIDIA maintains strong positioning despite its massive $4.31T market cap and 63.1% profit margin demonstrating exceptional operational efficiency.
• Component Grades: The company excels with an A grade in Financials, reflecting its robust balance sheet with $206.8B in assets against only $49.5B in liabilities, while also earning a B in both Sentiment and Artificial Intelligence categories. See all 7 Zen Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.